Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casea S Contraceptive Implants Phase 1 Study
NCT05174884Phase 1Active, not recruiting
- Sponsor
- FHI 360
- Start
- Dec 2023
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of etonogestrel in contraception (2 arms), sponsored by FHI 360. Primary endpoints: Maximum observed serum concentration at 114 weeks, Time to Cmax at 114 weeks and 5 more. Started Dec 2023; status: active, not recruiting.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05174884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05174884.